Saia John G. sold 6 shares of Guardant Health, Inc. at $126.08 for −$756 on May 27, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Legal Officer
Chief Legal Officer
Filed May 28, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$756.48Shares × reported price
Shares traded
6Common Stock
Price per share
$126.08Reported price. Read footnotes for ranges.
% of reported position traded
0.02%This security and ownership context
Holdings after
35,950Direct
Trade date
May 27, 2026Sell
Filed
May 28, 2026, 6:32 PM ET1-day reporting delay
Accession
0001737840-26-000014Code S · Transaction 386545
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 35,956 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 27, 2026Sell9,994$125.08−$1,250,079.50Trade 386544
2 transaction rows in this filing. Joint filers share the same rows.

GH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
GH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −34%1w ago −14%1d ago −10%
Returns since7d −0.1%30d +12%90d +28%180d1y

Footnotes in full

F1: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $125.00 to $125.44. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.